1. Home
  2. Live Updates
  3. Movement disorder society

Live Breaking News & Updates on Movement disorder society

Stay informed with the latest breaking news from Movement disorder society on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Movement disorder society and stay connected to the pulse of your community

Lixisenatide Decreases Motor Disability Progression in Early Parkinson Disease

Among patients with PD, lixisenatide is associated with a decrease in motor disability progression and has gastrointestinal side effects.

France , Movement-disorder-society , New-england-journal , Unified-parkinson , Disease-rating-scale ,

GlobalData : Roche's PRX-002 shows promise in slowing Parkinson's disease motor progression, says GlobalData

19 Apr, 2024 Roche's PRX-002 shows promise in slowing Parkinson's disease motor progression, says GlobalData



Share


Print...

United-states , American , Lorraine-palmer , Parkinson-progression-marker-initiative , Movement-disorder-society , American-academy-of-neurology , American-academy , Pharma-analyst , Progression-marker-initiative , Movement-disorder-society-sponsored-revision , Unified-parkinson , Disease-rating-scale

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Constance-brown , Raymond-sanchez , Huberth-fernandez , Clinical-development-program , Movement-disorder-society , Neurological-restoration , Disease-rating-scale , Cerevel-therapeutics , Note-regarding-forward-looking

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson's patients

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson's patients
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

France , Montreal , Quebec , Canada , Movement-disorder-society , New-england-journal , Early-parkinson , Image-credit , Disease-questionnaire , Unified-parkinson , Disease-rating-scale

Two Johns Hopkins alumni, two graduate students named Paul and Daisy Soros Fellows

They are among 30 recipients of the fellowships, which honor immigrants and children of immigrants with exceptional potential to make a difference in their fields

South-korea , Stanford , Leicestershire , United-kingdom , University-of-pennsylvania , Pennsylvania , United-states , Thailand , New-jersey , Zhejiang , China , India

Sun Pharma Advanced slips 5% on halting Parkinson's drug trial

The Sun Pharma Advanced Research Company stock has gained 40 percent this year against a 4 percent rise in the benchmark Nifty50

United-states , Mumbai , Maharashtra , India , Sun-pharma-advanced-research-company , National-stock-exchange , Movement-disorder-society , Unified-parkinson , Disease-rating-scale , Sun-pharma-advanced-research-company-share-price-today , Un-pharma-advanced-research-company-share-price-update

Gut microbiome shows no clear link to cognitive impairments in Parkinson's disease

Study investigates the gut microbiome's role in Parkinson's disease patients with mild cognitive impairments, revealing no distinct microbiome signatures associated with MCI in PD compared to cognitively normal PD patients or controls.

United-kingdom , Rome , Lazio , Italy , Montreal , Quebec , Canada , Luxembourg , Movement-disorder-society , United-kingdom-pd-society-brain-bank , Brain-bank

Lixisenatide Reduces Motor Disability Progression in Parkinson Disease

Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson disease

France , French , Wassiliosg-meissner , Movement-disorder-in-toulouse , French-clinical-research-network-for-parkinson-disease , Movement-disorder-society , Healthday-news , New-england-journal , French-clinical-research-network , Movement-disorder , Movement-disorder-society-unified-parkinson

Diabetes Drug Shows Benefit in Parkinson's Disease

Phase II study of GLP-1 drug lixisenatide meets primary endpoint

France , David-standaert , Olivier-rascol , Judy-george , Movement-disorder-society , University-of-toulouse , University-of-alabama-at-birmingham , Movement-disorder-society-unified-parkinson , Disease-rating-scale , New-england-journalof , Medpage-today , England-journal

Diets impact Parkinson's motor symptoms, supplements show no benefit, study finds

Meta-analysis reveals that diets like the Mediterranean and ketogenic can improve motor function in Parkinson's disease patients, although dietary supplements do not enhance UPDRS or 6MWT scores.

Wanfang , Jiangxi , China , Weipu , Fujian , Cochrane-library , International-prospective-register-of-systematic-reviews , International-parkinson , Movement-disorder-society , China-national-knowledge-infrastructure , European-journal